Italia markets open in 7 hours 58 minutes

Abeona Therapeutics Inc. (ABEO)

NasdaqCM - NasdaqCM Prezzo in tempo reale. Valuta in USD.
Aggiungi a portafoglio
1,18000,0000 (0,00%)
Alla chiusura: 4:00PM EDT
1,1900 0,01 (0,85%)
Dopo ore: 06:36PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente1,1800
Aperto1,1700
Denaro1,1700 x 1000
Lettera1,1800 x 3000
Min-Max giorno1,1300 - 1,1938
Intervallo di 52 settimane0,9900 - 3,7900
Volume750.639
Media Volume846.350
Capitalizzazione119,448M
Beta (5 anni mensile)1,42
Rapporto PE (ttm)N/D
EPS (ttm)-0,5770
Prossima data utili08 nov 2021 - 12 nov 2021
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1A5,00
  • GlobeNewswire

    Abeona Announces New Chairman, Executive Leadership Promotions and Key Talent Additions for Final Push Towards Two Biologics License Application (BLA) Filings

    Steven H. Rouhandeh to retire as Chairman of the Board; Michael Amoroso appointed Chairman of the Board Vishwas Seshadri, Ph.D., M.B.A. to become Chief Executive Officer Brendan M. O’Malley, J.D., Ph.D. promoted to General Counsel, Brian Kevany, Ph.D. promoted to Chief Technical Officer, Scott Nogi, M.B.A., Head of Business Operations to expand role and lead operations at Abeona’s Cleveland facility Regulatory veterans in AAV-based gene therapy, Carl Denny and Kate Imhoff, added to team in prepa

  • GlobeNewswire

    Abeona Therapeutics to Present at Upcoming Investor Conferences

    NEW YORK and CLEVELAND, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that members of the company’s management will present and conduct one-on-one meetings at the following virtual investor conferences: Citi’s 16th Annual BioPharma Virtual Conference on September 8-10, 2021 (one-on-one meetings only).H.C. Wainwright 23rd Annual Global Investment Conference. The pre-recorded presentation will be avai